(2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide

C160H186F4N26O6 — CID 158084012

IUPAC(2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide
SMILESCc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCC(F)(F)CC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCCC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCN(C)CC3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCC(F)(F)CC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCCC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCN(C)CC3)nc2)c2ccccc2)cc1
InChIInChI=1S/2C27H30F2N4O.2C27H33N5O.2C26H30N4O/c2*1-20-7-9-21(10-8-20)13-16-30-25(22-5-3-2-4-6-22)26(34)32-24-12-11-23(19-31-24)33-17-14-27(28,29)15-18-33;2*1-21-8-10-22(11-9-21)14-15-28-26(23-6-4-3-5-7-23)27(33)30-24-12-13-25(29-20-24)32-18-16-31(2)17-19-32;2*1-20-9-11-21(12-10-20)15-16-27-25(22-7-3-2-4-8-22)26(31)29-24-14-13-23(19-28-24)30-17-5-6-18-30/h2*2-12,19,25,30H,13-18H2,1H3,(H,31,32,34);2*3-13,20,26,28H,14-19H2,1-2H3,(H,30,33);2*2-4,7-14,19,25,27H,5-6,15-18H2,1H3,(H,28,29,31)/t2*25-;2*26-;2*25-/m101010/s1
InChIKeyFNHJHTCNRZUBLG-KZSYCWHOSA-N
MW2645.42 g/mol
LogP26.59
Rot. Bonds48

About (2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide

(2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide (PubChem CID 158084012) has the molecular formula C160H186F4N26O6 and a molecular weight of 2645.42 g/mol. Its IUPAC name is (2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide.

Molecular Properties

Compound Name(2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide
PubChem CID158084012
Molecular FormulaC160H186F4N26O6
Molecular Weight2645.42 g/mol
Exact Mass2643.50
IUPAC Name(2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide
SMILESCc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCC(F)(F)CC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCCC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCN(C)CC3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCC(F)(F)CC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCCC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCN(C)CC3)nc2)c2ccccc2)cc1
InChIInChI=1S/2C27H30F2N4O.2C27H33N5O.2C26H30N4O/c2*1-20-7-9-21(10-8-20)13-16-30-25(22-5-3-2-4-6-22)26(34)32-24-12-11-23(19-31-24)33-17-14-27(28,29)15-18-33;2*1-21-8-10-22(11-9-21)14-15-28-26(23-6-4-3-5-7-23)27(33)30-24-12-13-25(29-20-24)32-18-16-31(2)17-19-32;2*1-20-9-11-21(12-10-20)15-16-27-25(22-7-3-2-4-8-22)26(31)29-24-14-13-23(19-28-24)30-17-5-6-18-30/h2*2-12,19,25,30H,13-18H2,1H3,(H,31,32,34);2*3-13,20,26,28H,14-19H2,1-2H3,(H,30,33);2*2-4,7-14,19,25,27H,5-6,15-18H2,1H3,(H,28,29,31)/t2*25-;2*26-;2*25-/m101010/s1
InChIKeyFNHJHTCNRZUBLG-KZSYCWHOSA-N
XLogP26.59
TPSA350.04 Ų
H-Bond Donors12
H-Bond Acceptors26
Rotatable Bonds48
Heavy Atoms196
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002645.42
LogP ≤ 526.59
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1026

Analyze (2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide?
The IUPAC name of (2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide (CID 158084012) is (2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide.
What is the SMILES notation for (2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide?
The canonical SMILES for (2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide is Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCC(F)(F)CC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCCC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(N3CCN(C)CC3)nc2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCC(F)(F)CC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCCC3)cn2)c2ccccc2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(N3CCN(C)CC3)nc2)c2ccccc2)cc1.
What is the InChIKey of (2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide?
The InChIKey is FNHJHTCNRZUBLG-KZSYCWHOSA-N. The full InChI is InChI=1S/2C27H30F2N4O.2C27H33N5O.2C26H30N4O/c2*1-20-7-9-21(10-8-20)13-16-30-25(22-5-3-2-4-6-22)26(34)32-24-12-11-23(19-31-24)33-17-14-27(28,29)15-18-33;2*1-21-8-10-22(11-9-21)14-15-28-26(23-6-4-3-5-7-23)27(33)30-24-12-13-25(29-20-24)32-18-16-31(2)17-19-32;2*1-20-9-11-21(12-10-20)15-16-27-25(22-7-3-2-4-8-22)26(31)29-24-14-13-23(19-28-24)30-17-5-6-18-30/h2*2-12,19,25,30H,13-18H2,1H3,(H,31,32,34);2*3-13,20,26,28H,14-19H2,1-2H3,(H,30,33);2*2-4,7-14,19,25,27H,5-6,15-18H2,1H3,(H,28,29,31)/t2*25-;2*26-;2*25-/m101010/s1.
What are the key properties of (2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide?
(2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide has a molecular weight of 2645.42 g/mol, XLogP of 26.59, 48 rotatable bonds, 12 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(4,4-difluoropiperidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-2-phenylacetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-2-phenyl-N-(5-pyrrolidin-1-yl-2-pyridinyl)acetamide is sourced from PubChem (CID 158084012), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).